RxDoctor Payments Data

Randy Trimpey, MD

Family Medicine · Bowling Green, OHNPI 1588668255

Payments from drug & device makers

$387in general payments, 2019–2025

Across 23 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$68
  • AbbVie$63
  • GSK$42
  • Pfizer$37
  • Corium, LLC$28
  • Abbott$26
  • plus $124 from 7 others

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$143,957
Medicare patients
319
Services billed
2,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin84$113,538
EliquisApixaban65$81,867
OzempicSemaglutide65$74,750
FarxigaDapagliflozin Propanediol50$50,582
JanuviaSitagliptin Phosphate32$36,227
TrulicityDulaglutide26$25,736
Breo ElliptaFluticasone/Vilanterol47$25,136
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog47$24,488
MounjaroTirzepatide23$22,336
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$17,077
Lantus SolostarInsulin Glargine,hum.Rec.Anlog102$16,033
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$13,830
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$12,271
Emgality PenGalcanezumab-Gnlm16$10,353
Incruse ElliptaUmeclidinium Bromide26$10,195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$81,86765 claims
Novo NordiskOzempic$68$74,75065 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta$42$52,40896 claims
Lilly USA, LLCTrulicity, Mounjaro$18$48,07249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Bowling Green

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →